Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
View ORCID ProfileAlex Handy, View ORCID ProfileAmitava Banerjee, View ORCID ProfileAngela Wood, Caroline E Dale, View ORCID ProfileCathie Sudlow, View ORCID ProfileChristopher Tomlinson, View ORCID ProfileDaniel Bean, View ORCID ProfileJohan H Thygesen, View ORCID ProfileMehrdad A Mizani, View ORCID ProfileMichail Katsoulis, View ORCID ProfileReecha Sofat, View ORCID ProfileRichard Dobson, Rohan Takhar, Sam Hollings, View ORCID ProfileSpiros Denaxas, View ORCID ProfileVenexia Walker on behalf of the CVD-COVID-UK Consortium
doi: https://doi.org/10.1101/2021.09.03.21263023
Alex Handy
1Institute of Health Informatics, University College London, London, UK
Amitava Banerjee
1Institute of Health Informatics, University College London, London, UK
2University College London Hospitals NHS Trust, London, UK
3Barts Health NHS Trust, The Royal London Hospital, London, UK
Angela Wood
4British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
5British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
6Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
7National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
8The Alan Turing Institute, London, UK
Caroline E Dale
1Institute of Health Informatics, University College London, London, UK
Cathie Sudlow
9Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
10British Heart Foundation Data Science Centre, Health Data Research UK, London, UK
11Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK
Christopher Tomlinson
1Institute of Health Informatics, University College London, London, UK
2University College London Hospitals NHS Trust, London, UK
12UKRI Centre for Doctoral Training in AI-enabled Healthcare Systems, University College London, London, UK
13National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK
Daniel Bean
14NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK
15Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
16Health Data Research UK London, University College London, London, UK
Johan H Thygesen
1Institute of Health Informatics, University College London, London, UK
Mehrdad A Mizani
1Institute of Health Informatics, University College London, London, UK
Michail Katsoulis
1Institute of Health Informatics, University College London, London, UK
Reecha Sofat
1Institute of Health Informatics, University College London, London, UK
Richard Dobson
1Institute of Health Informatics, University College London, London, UK
13National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK
14NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, UK
15Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
16Health Data Research UK London, University College London, London, UK
Rohan Takhar
1Institute of Health Informatics, University College London, London, UK
Sam Hollings
17NHS Digital, Leeds, UK
Spiros Denaxas
1Institute of Health Informatics, University College London, London, UK
13National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK
18British Heart Foundation Research Accelerator, University College London, London, UK
Venexia Walker
19Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted September 10, 2021.
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
Alex Handy, Amitava Banerjee, Angela Wood, Caroline E Dale, Cathie Sudlow, Christopher Tomlinson, Daniel Bean, Johan H Thygesen, Mehrdad A Mizani, Michail Katsoulis, Reecha Sofat, Richard Dobson, Rohan Takhar, Sam Hollings, Spiros Denaxas, Venexia Walker
medRxiv 2021.09.03.21263023; doi: https://doi.org/10.1101/2021.09.03.21263023
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
Alex Handy, Amitava Banerjee, Angela Wood, Caroline E Dale, Cathie Sudlow, Christopher Tomlinson, Daniel Bean, Johan H Thygesen, Mehrdad A Mizani, Michail Katsoulis, Reecha Sofat, Richard Dobson, Rohan Takhar, Sam Hollings, Spiros Denaxas, Venexia Walker
medRxiv 2021.09.03.21263023; doi: https://doi.org/10.1101/2021.09.03.21263023
Subject Area
Subject Areas
- Addiction Medicine (337)
- Allergy and Immunology (664)
- Anesthesia (179)
- Cardiovascular Medicine (2607)
- Dermatology (220)
- Emergency Medicine (392)
- Epidemiology (12150)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4038)
- Geriatric Medicine (381)
- Health Economics (672)
- Health Informatics (2609)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (834)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3810)
- Nursing (208)
- Nutrition (567)
- Oncology (1997)
- Ophthalmology (580)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1103)
- Primary Care Research (443)
- Public and Global Health (6478)
- Radiology and Imaging (1380)
- Respiratory Medicine (867)
- Rheumatology (396)
- Sports Medicine (337)
- Surgery (439)
- Toxicology (52)
- Transplantation (185)
- Urology (165)